Patents by Inventor Helmuth Schutz

Helmuth Schutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6291515
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 18, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz
  • Patent number: 6225337
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: May 1, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz
  • Patent number: 5866571
    Abstract: 9-Substituted 2-(2-n-alkoxyphenyl)purin-6-ones are prepared by cyclizing correspondingly substituted imidazoles and derivatizing the purines thus obtained. The 9-substituted .sup.2 -(2-n-alkoxyphenyl)purin-6-ones can be employed as active compounds in medicaments, in particular in medicarnents for treatment of inflammations, thromboembolic diseases and cardiovascular diseases.
    Type: Grant
    Filed: January 16, 1996
    Date of Patent: February 2, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ulrich Niewohner, Erwin Bischoff, Helmuth Schutz, Elisabeth Perzborn, Matthias Schramm
  • Patent number: 5861404
    Abstract: 2,9-Disubstituted purin-6-ones are prepared by acylating correspondingly substituted aminoimidazoles in a first step and then cyclizing the product to the purine. The new 2,9-disubstituted purin-6-ones can be employed as active compounds in medicaments, in particular for the treatment of inflammations, thromboembolic and cardiovascular diseases and diseases of the urogenital system.
    Type: Grant
    Filed: January 12, 1996
    Date of Patent: January 19, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ulrich Niewohner, Erwin Bischoff, Helmuth Schutz, Elisabeth Perzborn, Matthias Schramm
  • Patent number: 5861396
    Abstract: Purin-6-one derivatives are prepared by acylating appropriately substituted imidazole carboxamides and then cyclizing to give the purines. The purin-6-one derivatives are suitable as active compounds in medicaments, in particular for the treatment of cardiovascular disorders, disorders of the vascular system and of the urogenital system.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: January 19, 1999
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ulrich Niewohner, Erwin Bischoff, Joachim Hutter, Elisabeth Perzborn, Helmuth Schutz
  • Patent number: 5721238
    Abstract: 2,8-Disubstituted quinazolinones are prepared by first subjecting the quinazolinone basic skeleton to condensation by customary reactions and then introducing the desired substituents into the 8-position. The compounds are suitable as active compounds in medicaments, in particular for the treatment of inflammations, thromboembolic diseases and cardiovascular diseases.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: February 24, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Fred Robert Heiker, Ulrich Niewohner, Wolfgang Hartwig, Helmuth Schutz, Erwin Bischoff, Elisabeth Perzborn, Matthias Schramm